| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药流通(元) | 286,122,615.24 | 208,535,547.48 | 147,287,981.63 |
| 医药制造(元) | 1,136,958,433.68 | 1,728,707,551.77 | 1,639,637,242.25 |
| 营业成本(元) | |||
| 医药流通(元) | 245,412,630.12 | 165,084,512.46 | 119,219,222.93 |
| 医药制造(元) | 287,233,297.00 | 445,235,218.43 | 408,250,633.61 |
| 毛利(元) | |||
| 医药流通(元) | 40,709,985.12 | 43,451,035.02 | 28,068,758.70 |
| 医药制造(元) | 849,725,136.68 | 1,283,472,333.34 | 1,231,386,608.64 |
| 毛利率(%) | |||
| 医药流通(%) | 14.23 | 20.84 | 19.06 |
| 医药制造(%) | 74.74 | 74.24 | 75.10 |
| 收入构成(%) | |||
| 医药流通(%) | 20.11 | 10.76 | 8.24 |
| 医药制造(%) | 79.89 | 89.24 | 91.76 |
| 毛利构成(%) | |||
| 医药流通(%) | 4.57 | 3.27 | 2.23 |
| 医药制造(%) | 95.43 | 96.73 | 97.77 |